ELICIO THERAPEUTICS INC (ELTX) Stock Analyst Earnings Estimates
NASDAQ:ELTX - Nasdaq - US28657F1030 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.88M 93.29% | 28.31M 882.99% | 2.3M -91.88% | -100.00% | 1.02M | 5.1M 400.00% | 12.24M 140.00% | 20.4M 66.67% | ||||||
| EBITDA YoY % growth | -55.17M -43.15% | -39.22M 28.91% | -30.25M 22.87% | -41.83M -16.90% | -46.657M -31.94% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -55.27M -43.22% | -39.31M 28.88% | -30.43M 22.59% | -31.405M -17.47% | -43.247M -20.99% | -46.567M -7.68% | -51.685M -10.99% | -46.614M 9.81% | -50.898M -9.19% | N/A | N/A | N/A | N/A | |
| Operating Margin | -1,919.10% | -138.86% | -1,323.04% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -2.09 96.47% | -12.90 -517.22% | -5.56 56.91% | -4.00 28.13% | -3.00 24.94% | -2.45 18.37% | -1.26 48.33% | -1.16 8.06% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.90 48.71% | -0.74 35.25% | -0.68 -6.78% | -0.69 50.10% | -0.70 21.59% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.061M -17.77% | -11.023M -7.64% | -11.217M -2.68% | -11.415M 2.26% | -11.616M -5.01% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.39 -9.45% | -0.74 | -0.65 | -86.68% |
| Q2 2024 Q2Q % growth | -0.64 | -0.98 | 0.34 | 34.64% |
| Q1 2024 Q2Q % growth | -1.15 | -1.11 | -0.04 | -3.44% |
| Q4 2023 Q2Q % growth | -1.75 16.67% | -0.80 | -0.95 | -118.56% |
| Q3 2023 Q2Q % growth | -1.27 57.67% | -0.82 | -0.45 | -55.64% |
| Q4 2022 Q2Q % growth | -2.10 -462.07% | -2.14 | 0.04 | 1.96% |
| Q3 2022 Q2Q % growth | -3.00 -466.04% | -3.67 | 0.67 | 18.30% |
| Q2 2022 Q2Q % growth | -3.00 -417.24% | -4.73 | 1.73 | 36.52% |
| Q1 2022 Q2Q % growth | -4.80 -207.69% | -4.44 | -0.36 | -8.18% |
| Q4 2021 Q2Q % growth | 0.58 130.53% | -0.63 | 1.21 | 192.09% |
| Q3 2021 Q2Q % growth | -0.53 | -0.74 | 0.21 | 28.33% |
| Q2 2021 Q2Q % growth | -0.58 | -0.70 | 0.12 | 17.29% |
| Q1 2021 Q2Q % growth | -1.56 | -0.63 | -0.93 | -145.69% |
| Q4 2020 Q2Q % growth | -1.90 | -1.33 | -0.57 | -43.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2022 Q2Q % growth | -100.00% | 833.003K | -833.003K | -100.00% |
| Q2 2022 Q2Q % growth | 650K 20.37% | 1.377M | -727K | -52.80% |
| Q1 2022 Q2Q % growth | 1.65M 345.95% | 937.125K | 712.875K | 76.07% |
| Q4 2021 Q2Q % growth | 25.94M 5,539.13% | 1.772M | 24.168M | 1,363.88% |
| Q3 2021 Q2Q % growth | 1.46M | 1.084M | 376K | 34.69% |
| Q2 2021 Q2Q % growth | 540K -26.03% | 476.003K | 63.997K | 13.44% |
| Q1 2021 Q2Q % growth | 370K | 1.925M | -1.555M | -80.78% |
| Q4 2020 Q2Q % growth | 460K -34.29% | 1.938M | -1.478M | -76.26% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -18.33% |
| Revenue | N/A | N/A | N/A | N/A |